XML 17 R4.htm IDEA: XBRL DOCUMENT v3.21.2
Condensed Consolidated Balance Sheets (Unaudited) - USD ($)
$ in Millions
Sep. 30, 2021
Dec. 31, 2020
Assets:    
Cash and cash equivalents $ 9,826 $ 7,854
Investments 3,015 3,000
Accounts receivable, net 25,283 21,742
Inventories 17,399 18,496
Other current assets 5,319 5,277
Total current assets 60,842 56,369
Long-term investments 22,370 20,812
Property and equipment, net 12,771 12,606
Operating lease right-of-use assets 20,462 20,729
Goodwill 79,121 79,552
Intangible assets, net 29,545 31,142
Separate accounts assets 5,086 4,881
Other assets 4,694 4,624
Total assets 234,891 230,715
Liabilities:    
Accounts payable 12,696 11,138
Pharmacy claims and discounts payable 17,895 15,795
Health care costs payable 8,877 7,936
Policyholders’ funds 4,444 4,270
Accrued expenses 16,140 14,243
Other insurance liabilities 1,287 1,557
Current portion of operating lease liabilities 1,809 1,638
Current portion of long-term debt 1,561 5,440
Total current liabilities 64,709 62,017
Long-term operating lease liabilities 18,456 18,757
Long-term debt 56,832 59,207
Deferred income taxes 6,329 6,794
Separate accounts liabilities 5,086 4,881
Other long-term insurance liabilities 6,551 7,007
Other long-term liabilities 2,310 2,351
Total liabilities 160,273 161,014
Shareholders’ equity:    
Preferred stock, par value $0.01: 0.1 shares authorized; none issued or outstanding 0 0
Common stock, par value $0.01: 3,200 shares authorized; 1,743 shares issued and 1,321 shares outstanding at September 30, 2021 and 1,733 shares issued and 1,310 shares outstanding at December 31, 2020 and capital surplus 47,133 46,513
Treasury stock, at cost: 422 shares at September 30, 2021 and 423 shares at December 31, 2020 (28,166) (28,178)
Retained earnings 54,264 49,640
Accumulated other comprehensive income 1,077 1,414
Total CVS Health shareholders’ equity 74,308 69,389
Noncontrolling interests 310 312
Total shareholders’ equity 74,618 69,701
Total liabilities and shareholders’ equity $ 234,891 $ 230,715